Ranitidine is an H2 blocker that is used in prescription strength for duodenal and gastric ulcers, gastroesophageal reflux, and as part of a multidrug regimen for the eradication of H. pylori to reduce the risk of duodenal ulcer recurrence.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Acid reflux (GER gastroesophageal reflux) | 35 |
|
|
|
8 | ||
| Other | 22 |
|
|
3 | |||
| Stomach ache | 6 | 0 | |||||
| Irritable Bowel Syndrome (IBS) | 3 |
|
1 | ||||
| General health | 2 | 0 | |||||
| Diarrhea | 2 | 0 |
See all 86 patients currently taking Ranitidine Prescription
Mouse over the table for more information
Top 10 dosages based on patients currently taking Ranitidine Prescription. See all 18 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
4 | 40% |
|
|
Course of treatment ended
|
3 | 30% |
|
|
Expense
|
1 | 10% |
|
|
Side effects too severe
|
1 | 10% |
|
|
Not indicated
|
1 | 10% |
|
See all 9 patients who’ve stopped taking Ranitidine Prescription
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.